MedMij:V1.0 MP9.0.7-AddendaInhoudelijkeGegevensVV: verschil tussen versies
Naar navigatie springen
Naar zoeken springen
k (Tekst vervangen - "{{#customtitle:" door "{{DISPLAYTITLE:") |
|||
| (9 tussenliggende versies door een andere gebruiker niet weergegeven) | |||
| Regel 1: | Regel 1: | ||
__NUMBEREDHEADINGS__ | __NUMBEREDHEADINGS__ | ||
| − | {{ | + | {{DISPLAYTITLE:Raadplegen verstrekkingenvertaling 9.0.7: addendum inhoudelijke gegevens kwalificatie}} |
[[Bestand:Nictiz_logo_PO_rechts_rgb.png |link=https://www.nictiz.nl/|rechts|Naar nictiz.nl]] | [[Bestand:Nictiz_logo_PO_rechts_rgb.png |link=https://www.nictiz.nl/|rechts|Naar nictiz.nl]] | ||
| Regel 63: | Regel 63: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|tot nader order, gebruik bekend | |style="background-color: white;"|tot nader order, gebruik bekend | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|38129f10-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|38129f10-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|}<section end=TA_Henegouwen /> | |}<section end=TA_Henegouwen /> | ||
===Verstrekkingen Henegouwen === | ===Verstrekkingen Henegouwen === | ||
| Regel 84: | Regel 81: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|38129f10-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|38129f10-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
| Regel 108: | Regel 105: | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"|MEBENDAZOL SAN TABLET 100MG (code = '14234785' in codeSystem 'G-Standaard Artikel') | |style="background-color: white;"|MEBENDAZOL SAN TABLET 100MG (code = '14234785' in codeSystem 'G-Standaard Artikel') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '1046764' in codeSystem '2.16.840.1.113883.2.4.4.7') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '9954' in codeSystem '2.16.840.1.113883.2.4.4.1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|38129f10-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|38129f10-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|}<section end=MVE_Henegouwen /> | |}<section end=MVE_Henegouwen /> | ||
==Patiënt Carel C. Creiens== | ==Patiënt Carel C. Creiens== | ||
| Regel 167: | Regel 170: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|gedurende 7 dagen, 4 maal per dag 1 tablet | |style="background-color: white;"|gedurende 7 dagen, 4 maal per dag 1 tablet | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| Regel 179: | Regel 179: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|1f5eebe0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|1f5eebe0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 213: | Regel 213: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|tot nader order, 3 maal per dag 1 zakje | |style="background-color: white;"|tot nader order, 3 maal per dag 1 zakje | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| Regel 225: | Regel 222: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|47f39010-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|47f39010-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 259: | Regel 256: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|gedurende 1826 dagen, 2 maal per jaar 1 injectie | |style="background-color: white;"|gedurende 1826 dagen, 2 maal per jaar 1 injectie | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| Regel 271: | Regel 265: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|4d5128b0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|4d5128b0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 311: | Regel 305: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|gedurende 60 dagen, 1 maal per dag een kwart tablet | |style="background-color: white;"|gedurende 60 dagen, 1 maal per dag een kwart tablet | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| Regel 323: | Regel 314: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|52c41e10-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|52c41e10-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 363: | Regel 354: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|gedurende 21 dagen, 1 maal per week 15 ml | |style="background-color: white;"|gedurende 21 dagen, 1 maal per week 15 ml | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| Regel 375: | Regel 363: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|59df4530-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|59df4530-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 415: | Regel 403: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|Vanaf T- 650 dagen, gedurende 7 dagen, 2 maal per dag 1 druppel | |style="background-color: white;"|Vanaf T- 650 dagen, gedurende 7 dagen, 2 maal per dag 1 druppel | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| Regel 427: | Regel 412: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|5ed2f870-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|5ed2f870-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 467: | Regel 452: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|Vanaf T- 287 dagen, tot nader order, 2 maal per dag 5 gram | |style="background-color: white;"|Vanaf T- 287 dagen, tot nader order, 2 maal per dag 5 gram | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| Regel 479: | Regel 461: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|63c23ee0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|63c23ee0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 519: | Regel 501: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|Vanaf T- 71 dagen, tot en met T+ 149 dagen, om 23:59, 2 maal per dag 2 inhalaties | |style="background-color: white;"|Vanaf T- 71 dagen, tot en met T+ 149 dagen, om 23:59, 2 maal per dag 2 inhalaties | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| Regel 531: | Regel 510: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|6898f440-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|6898f440-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 571: | Regel 550: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|gedurende 18 dagen, 1 maal per 3 dagen 2 pleisters | |style="background-color: white;"|gedurende 18 dagen, 1 maal per 3 dagen 2 pleisters | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"|1 maal per 3 | + | |style="background-color: white;"|1 maal per 3 dagen 2 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|6da7a990-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|6da7a990-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 620: | Regel 596: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|gedurende 30 dagen, gebruik volgens afspraak | |style="background-color: white;"|gedurende 30 dagen, gebruik volgens afspraak | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|721def70-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|721def70-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 642: | Regel 615: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: white;"|Vanaf T, tot en met | + | |style="background-color: white;"|Vanaf T, tot en met T+ 42 dagen, om 00:00 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
| Regel 666: | Regel 639: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"|Vanaf T, tot en met | + | |style="background-color: white;"|Vanaf T, tot en met T+ 42 dagen, om 00:00, eerst 1 week 6 stuks per dag; vanaf T + 1wk, gedurende 1 week 5 stuks per dag; vanaf T + 2 weken, gedurende 1 week 4 stuks per dag; vanaf T + 3 weken, gedurende 1 week 3 stuks per dag; vanaf T + 4 weken, gedurende 1 week 2 stuks per dag; vanaf T + 5 weken, gedurende 1 week 1 stuks per dag |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|78074d50-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|78074d50-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|}<section end=TA_Creiens /> | |}<section end=TA_Creiens /> | ||
===Verstrekkingen Creiens === | ===Verstrekkingen Creiens === | ||
| Regel 687: | Regel 657: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|1f5eebe0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|1f5eebe0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
| Regel 713: | Regel 683: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|1f5eebe0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|1f5eebe0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 723: | Regel 693: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|47f39010-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|47f39010-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
| Regel 747: | Regel 717: | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"|ORS POEDER SACHET 5,4G SAN (code = '14565277' in codeSystem 'G-Standaard Artikel') | |style="background-color: white;"|ORS POEDER SACHET 5,4G SAN (code = '14565277' in codeSystem 'G-Standaard Artikel') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '1417762' in codeSystem '2.16.840.1.113883.2.4.4.7') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verbruiksduur | |colspan="4"|Verbruiksduur | ||
| Regel 752: | Regel 725: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|47f39010-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|47f39010-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 762: | Regel 735: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|4d5128b0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|4d5128b0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
| Regel 788: | Regel 761: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verbruiksduur | |colspan="4"|Verbruiksduur | ||
| − | |style="background-color: white;"|5 | + | |style="background-color: white;"|5 jaar |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|4d5128b0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|4d5128b0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 801: | Regel 774: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|52c41e10-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|52c41e10-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
| Regel 825: | Regel 798: | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"|IBUPROFEN PCH TABLET 200MG CLICKER (code = '14765233' in codeSystem 'G-Standaard Artikel') | |style="background-color: white;"|IBUPROFEN PCH TABLET 200MG CLICKER (code = '14765233' in codeSystem 'G-Standaard Artikel') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '719374' in codeSystem '2.16.840.1.113883.2.4.4.7') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '50997' in codeSystem '2.16.840.1.113883.2.4.4.1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verbruiksduur | |colspan="4"|Verbruiksduur | ||
| Regel 830: | Regel 809: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|52c41e10-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|52c41e10-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 840: | Regel 819: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|59df4530-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|59df4530-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
| Regel 864: | Regel 843: | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"|KENACORT A 40 INJECTIESUSPENSIE 40MG/ML FLACON 5ML (code = '12128198' in codeSystem 'G-Standaard Artikel') | |style="background-color: white;"|KENACORT A 40 INJECTIESUSPENSIE 40MG/ML FLACON 5ML (code = '12128198' in codeSystem 'G-Standaard Artikel') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '219584' in codeSystem '2.16.840.1.113883.2.4.4.7') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '120219' in codeSystem '2.16.840.1.113883.2.4.4.1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|59df4530-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|59df4530-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 876: | Regel 861: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|5ed2f870-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|5ed2f870-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
| Regel 900: | Regel 885: | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"|TRUSOPT OOGDRUPPELS 20MG/ML FLACON 5ML (code = '13906550' in codeSystem 'G-Standaard Artikel') | |style="background-color: white;"|TRUSOPT OOGDRUPPELS 20MG/ML FLACON 5ML (code = '13906550' in codeSystem 'G-Standaard Artikel') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '850144' in codeSystem '2.16.840.1.113883.2.4.4.7') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '95575' in codeSystem '2.16.840.1.113883.2.4.4.1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|5ed2f870-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|5ed2f870-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 912: | Regel 903: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|63c23ee0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|63c23ee0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
| Regel 936: | Regel 927: | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"|RESONIUM A POEDER (code = '13650203' in codeSystem 'G-Standaard Artikel') | |style="background-color: white;"|RESONIUM A POEDER (code = '13650203' in codeSystem 'G-Standaard Artikel') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '15261' in codeSystem '2.16.840.1.113883.2.4.4.7') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '121363' in codeSystem '2.16.840.1.113883.2.4.4.1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|63c23ee0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|63c23ee0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 948: | Regel 945: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|6898f440-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|6898f440-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
| Regel 972: | Regel 969: | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"|SEREVENT DISKUS INHPDR 50MCG 60DO (code = '14039303' in codeSystem 'G-Standaard Artikel') | |style="background-color: white;"|SEREVENT DISKUS INHPDR 50MCG 60DO (code = '14039303' in codeSystem 'G-Standaard Artikel') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '1029746' in codeSystem '2.16.840.1.113883.2.4.4.7') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '87424' in codeSystem '2.16.840.1.113883.2.4.4.1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|6898f440-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|6898f440-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 984: | Regel 987: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|6da7a990-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|6da7a990-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
| Regel 1.008: | Regel 1.011: | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"|DUROGESIC 100 MATRIXPLEISTER 16,8MG (code = '13878956' in codeSystem 'G-Standaard Artikel') | |style="background-color: white;"|DUROGESIC 100 MATRIXPLEISTER 16,8MG (code = '13878956' in codeSystem 'G-Standaard Artikel') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '836982' in codeSystem '2.16.840.1.113883.2.4.4.7') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '122033' in codeSystem '2.16.840.1.113883.2.4.4.1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|6da7a990-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|6da7a990-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 1.020: | Regel 1.029: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|721def70-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|721def70-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
| Regel 1.044: | Regel 1.053: | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"|Carvedilol CF tablet 6,25mg (code = '14933349' in codeSystem 'G-Standaard Artikel') | |style="background-color: white;"|Carvedilol CF tablet 6,25mg (code = '14933349' in codeSystem 'G-Standaard Artikel') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|CARVEDILOL TABLET 6,25MG (code = '101451' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|721def70-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|721def70-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 1.056: | Regel 1.068: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|78074d50-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|78074d50-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
| Regel 1.080: | Regel 1.092: | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"|Diazepam PCH tablet 5mg (code = '13908790' in codeSystem 'G-Standaard Artikel') | |style="background-color: white;"|Diazepam PCH tablet 5mg (code = '13908790' in codeSystem 'G-Standaard Artikel') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|Diazepam tablet 5mg (code = '20664' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|78074d50-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|78074d50-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|}<section end=MVE_Creiens /> | |}<section end=MVE_Creiens /> | ||
==Patiënt Aygül A. Direnç== | ==Patiënt Aygül A. Direnç== | ||
| Regel 1.139: | Regel 1.154: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|gedurende 50 dagen, 3x per dag 8 tot 10 eenheid | |style="background-color: white;"|gedurende 50 dagen, 3x per dag 8 tot 10 eenheid | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| Regel 1.151: | Regel 1.163: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|d4d03380-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|d4d03380-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 1.188: | Regel 1.200: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|tot nader order, 1 tot 2 maal per dag 1 tablet | |style="background-color: white;"|tot nader order, 1 tot 2 maal per dag 1 tablet | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| Regel 1.200: | Regel 1.209: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|9b4c3b90-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|9b4c3b90-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 1.234: | Regel 1.243: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|tot nader order, 1 tot 3 keer per dag aanbrengen | |style="background-color: white;"|tot nader order, 1 tot 3 keer per dag aanbrengen | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Aanvullende instructie | |colspan="3"|Aanvullende instructie | ||
| Regel 1.249: | Regel 1.255: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|a378f9c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|a378f9c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 1.289: | Regel 1.295: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|gedurende 90 dagen, per 2 dagen 1 inhalatie | |style="background-color: white;"|gedurende 90 dagen, per 2 dagen 1 inhalatie | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"|1 maal per 2 | + | |style="background-color: white;"|1 maal per 2 dagen 1 dosis |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|a7e331b0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|a7e331b0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 1.335: | Regel 1.338: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|gedurende 168 dagen, Cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet | |style="background-color: white;"|gedurende 168 dagen, Cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| Regel 1.350: | Regel 1.350: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|ac8c4760-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|ac8c4760-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 1.387: | Regel 1.387: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|tot nader order, 1 tot 3 maal per week 1 tot 2 tabletten | |style="background-color: white;"|tot nader order, 1 tot 3 maal per week 1 tot 2 tabletten | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| Regel 1.399: | Regel 1.396: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|b1730250-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|b1730250-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 1.439: | Regel 1.436: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|gedurende 60 dagen, Elke dag om 8:00, 14:00 en 20:00 uur 16IE | |style="background-color: white;"|gedurende 60 dagen, Elke dag om 8:00, 14:00 en 20:00 uur 16IE | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| Regel 1.451: | Regel 1.445: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|b6d9e9c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|b6d9e9c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 1.491: | Regel 1.485: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="5"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|Vanaf T, om 15:48, gedurende 5 dagen, 2 maal per dag 4 milliliter, eerst oplossen in water, mond spoelen, daarna uitspugen | |style="background-color: white;"|Vanaf T, om 15:48, gedurende 5 dagen, 2 maal per dag 4 milliliter, eerst oplossen in water, mond spoelen, daarna uitspugen | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Aanvullende instructie | |colspan="3"|Aanvullende instructie | ||
| Regel 1.509: | Regel 1.500: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|bb7ee0c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|bb7ee0c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 1.522: | Regel 1.513: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: white;"|Vanaf T, tot en met | + | |style="background-color: white;"|Vanaf T, tot en met T+ 27 dagen, om 00:00 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
| Regel 1.543: | Regel 1.534: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"|Vanaf T, tot en met | + | |style="background-color: white;"|Vanaf T, tot en met T+ 27 dagen, om 00:00, Eerst, gedurende 2 weken, 3 gram per dag dun aanbrengen; daarna, gedurende 3 weken, 2 gram per dag dun aanbrengen ; daarna, gedurende 6 dagen, 1 gram per dag dun aanbrengen |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Aanvullende instructie | |colspan="3"|Aanvullende instructie | ||
| Regel 1.555: | Regel 1.543: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|c635f350-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|c635f350-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 1.589: | Regel 1.577: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|gedurende 48 dagen, 2x per dag 1/4 tablet | |style="background-color: white;"|gedurende 48 dagen, 2x per dag 1/4 tablet | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| Regel 1.601: | Regel 1.586: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|cbb37000-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|cbb37000-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 1.635: | Regel 1.620: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|gedurende 10 dagen, DAGDOSIS: 3 stuks per dag | |style="background-color: white;"|gedurende 10 dagen, DAGDOSIS: 3 stuks per dag | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|fbaecc50-4bec-11e5-b970-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|fbaecc50-4bec-11e5-b970-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|}<section end=TA_Direnç /> | |}<section end=TA_Direnç /> | ||
===Verstrekkingen Direnç === | ===Verstrekkingen Direnç === | ||
| Regel 1.656: | Regel 1.638: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|d4d03380-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|d4d03380-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
| Regel 1.682: | Regel 1.664: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|d4d03380-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|d4d03380-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 1.692: | Regel 1.674: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|9b4c3b90-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|9b4c3b90-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
| Regel 1.716: | Regel 1.698: | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '14165635' in codeSystem 'G-Standaard Artikel') | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '14165635' in codeSystem 'G-Standaard Artikel') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '1110837' in codeSystem '2.16.840.1.113883.2.4.4.7') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '103039' in codeSystem '2.16.840.1.113883.2.4.4.1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|9b4c3b90-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|9b4c3b90-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 1.728: | Regel 1.716: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|a378f9c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|a378f9c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
| Regel 1.752: | Regel 1.740: | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"|Cetomacrogolcreme met 10% vaseline fagron (code = '14344491' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Cetomacrogolcreme met 10% vaseline fagron (code = '14344491' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|a378f9c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|a378f9c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 1.764: | Regel 1.755: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|a7e331b0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|a7e331b0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
| Regel 1.788: | Regel 1.779: | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"|SPIRIVA INHALPDR 18 MCG (code = '14750406' in codeSystem 'G-Standaard Artikel') | |style="background-color: white;"|SPIRIVA INHALPDR 18 MCG (code = '14750406' in codeSystem 'G-Standaard Artikel') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '1476866' in codeSystem '2.16.840.1.113883.2.4.4.7') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '115371' in codeSystem '2.16.840.1.113883.2.4.4.1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|a7e331b0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|a7e331b0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 1.800: | Regel 1.797: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|ac8c4760-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|ac8c4760-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
| Regel 1.829: | Regel 1.826: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|ac8c4760-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|ac8c4760-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 1.839: | Regel 1.836: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|b1730250-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|b1730250-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
| Regel 1.863: | Regel 1.860: | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"|METFORMINE HCL CF TABLET 850MG (code = '15061078' in codeSystem 'G-Standaard Artikel') | |style="background-color: white;"|METFORMINE HCL CF TABLET 850MG (code = '15061078' in codeSystem 'G-Standaard Artikel') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '1037137' in codeSystem '2.16.840.1.113883.2.4.4.7') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '15865' in codeSystem '2.16.840.1.113883.2.4.4.1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verbruiksduur | |colspan="4"|Verbruiksduur | ||
| Regel 1.868: | Regel 1.871: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|b1730250-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|b1730250-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 1.878: | Regel 1.881: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|b6d9e9c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|b6d9e9c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
| Regel 1.902: | Regel 1.905: | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"|INSULATARD PENFILL INJ 100IE/ML PATR 3ML (code = '14815982' in codeSystem 'G-Standaard Artikel') | |style="background-color: white;"|INSULATARD PENFILL INJ 100IE/ML PATR 3ML (code = '14815982' in codeSystem 'G-Standaard Artikel') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '709085' in codeSystem '2.16.840.1.113883.2.4.4.7') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '111325' in codeSystem '2.16.840.1.113883.2.4.4.1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|b6d9e9c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|b6d9e9c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 1.914: | Regel 1.923: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|bb7ee0c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|bb7ee0c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
| Regel 1.939: | Regel 1.948: | ||
|style="background-color: white;"|FLUIMUCIL INHVLST 100MG/ML AMPUL 4ML (code = '13966383' in codeSystem 'G-Standaard Artikel') | |style="background-color: white;"|FLUIMUCIL INHVLST 100MG/ML AMPUL 4ML (code = '13966383' in codeSystem 'G-Standaard Artikel') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|MBH identificatie | + | |colspan="4"|Geneesmiddel - generiekere code |
| − | |style="background-color: white;"|bb7ee0c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|(code = '888567' in codeSystem '2.16.840.1.113883.2.4.4.7') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '38539' in codeSystem '2.16.840.1.113883.2.4.4.1') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MBH identificatie | ||
| + | |style="background-color: white;"|bb7ee0c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 1.950: | Regel 1.965: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|c635f350-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|c635f350-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
| Regel 1.979: | Regel 1.994: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|c635f350-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|c635f350-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 1.989: | Regel 2.004: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|cbb37000-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|cbb37000-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
| Regel 2.015: | Regel 2.030: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|cbb37000-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|cbb37000-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 2.025: | Regel 2.040: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|fbaecc50-4bec-11e5-b970-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|fbaecc50-4bec-11e5-b970-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
| Regel 2.051: | Regel 2.066: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|fbaecc50-4bec-11e5-b970-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|fbaecc50-4bec-11e5-b970-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|}<section end=MVE_Direnç /> | |}<section end=MVE_Direnç /> | ||
==Patiënt Hanneke XXX_Bekker== | ==Patiënt Hanneke XXX_Bekker== | ||
| Regel 2.105: | Regel 2.120: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|tot nader order, Zo nodig bij pijn, maximaal 6 stuks per dag | |style="background-color: white;"|tot nader order, Zo nodig bij pijn, maximaal 6 stuks per dag | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| Regel 2.117: | Regel 2.129: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|14606290-2dbd-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|14606290-2dbd-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 2.151: | Regel 2.163: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|gedurende 7 dagen, Gedurende 7 dagen, 1 keer per 4 uur 1 stuk | |style="background-color: white;"|gedurende 7 dagen, Gedurende 7 dagen, 1 keer per 4 uur 1 stuk | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| Regel 2.163: | Regel 2.172: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|13438b70-2dbe-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|13438b70-2dbe-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 2.198: | Regel 2.207: | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua | |style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua | ||
| − | + | Regel: Ureum 10 gr | |
| − | + | ||
| − | + | Regel: Eucerine met water creme FNA ad 100g. | |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Ingredient | |colspan="4"|Ingredient | ||
| Regel 2.224: | Regel 2.233: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|tot nader order, Zo nodig | |style="background-color: white;"|tot nader order, Zo nodig | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| Regel 2.236: | Regel 2.242: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|a083ca80-5772-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|a083ca80-5772-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|}<section end=TA_XXX_Bekker /> | |}<section end=TA_XXX_Bekker /> | ||
| + | |||
===Verstrekkingen XXX_Bekker === | ===Verstrekkingen XXX_Bekker === | ||
<section begin=MVE_XXX_Bekker /> | <section begin=MVE_XXX_Bekker /> | ||
| Regel 2.248: | Regel 2.255: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|14606290-2dbd-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|14606290-2dbd-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
| Regel 2.274: | Regel 2.281: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|14606290-2dbd-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|14606290-2dbd-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 2.284: | Regel 2.291: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|13438b70-2dbe-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|13438b70-2dbe-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
| Regel 2.310: | Regel 2.317: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|13438b70-2dbe-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|13438b70-2dbe-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 2.320: | Regel 2.327: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|a083ca80-5772-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|a083ca80-5772-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
| Regel 2.376: | Regel 2.383: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|a083ca80-5772-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|a083ca80-5772-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|}<section end=MVE_XXX_Bekker /> | |}<section end=MVE_XXX_Bekker /> | ||
==Patiënt Brooke B. van der Berken== | ==Patiënt Brooke B. van der Berken== | ||
| Regel 2.436: | Regel 2.443: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|gedurende 40 dagen, 3 maal per dag 1 Eetlepel (= 15ml) | |style="background-color: white;"|gedurende 40 dagen, 3 maal per dag 1 Eetlepel (= 15ml) | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| Regel 2.448: | Regel 2.452: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|e22b15e0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|e22b15e0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|}<section end=TA_Berken /> | |}<section end=TA_Berken /> | ||
===Verstrekkingen Berken === | ===Verstrekkingen Berken === | ||
| Regel 2.460: | Regel 2.464: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|e22b15e0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|e22b15e0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
| Regel 2.484: | Regel 2.488: | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"|NUTRIDRINK AARDBEI NR16642 (code = '13659847' in codeSystem 'G-Standaard Artikel') | |style="background-color: white;"|NUTRIDRINK AARDBEI NR16642 (code = '13659847' in codeSystem 'G-Standaard Artikel') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '710695' in codeSystem '2.16.840.1.113883.2.4.4.7') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verbruiksduur | |colspan="4"|Verbruiksduur | ||
| Regel 2.489: | Regel 2.496: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|e22b15e0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|e22b15e0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|}<section end=MVE_Berken /> | |}<section end=MVE_Berken /> | ||
==Patiënt B. B. van der Sluis== | ==Patiënt B. B. van der Sluis== | ||
| Regel 2.549: | Regel 2.556: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|gedurende 30 dagen, 3 maal per dag 1 Eetlepel (= 15ml) | |style="background-color: white;"|gedurende 30 dagen, 3 maal per dag 1 Eetlepel (= 15ml) | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| Regel 2.561: | Regel 2.565: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|84bd06a0-5d8a-11e7-9598-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|84bd06a0-5d8a-11e7-9598-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 2.598: | Regel 2.602: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|gedurende 30 dagen, 3 maal per dag 1 Eetlepel (= 15ml) | |style="background-color: white;"|gedurende 30 dagen, 3 maal per dag 1 Eetlepel (= 15ml) | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| Regel 2.610: | Regel 2.611: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|92955660-5d8a-11e7-9598-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|92955660-5d8a-11e7-9598-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|}<section end=TA_Sluis /> | |}<section end=TA_Sluis /> | ||
===Verstrekkingen Sluis === | ===Verstrekkingen Sluis === | ||
| Regel 2.622: | Regel 2.623: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|84bd06a0-5d8a-11e7-9598-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|84bd06a0-5d8a-11e7-9598-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
| Regel 2.646: | Regel 2.647: | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"|NUTRIDRINK AARDBEI (code = '15132714' in codeSystem 'G-Standaard Artikel') | |style="background-color: white;"|NUTRIDRINK AARDBEI (code = '15132714' in codeSystem 'G-Standaard Artikel') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '710695' in codeSystem '2.16.840.1.113883.2.4.4.7') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verbruiksduur | |colspan="4"|Verbruiksduur | ||
| Regel 2.651: | Regel 2.655: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|84bd06a0-5d8a-11e7-9598-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|84bd06a0-5d8a-11e7-9598-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 2.661: | Regel 2.665: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|92955660-5d8a-11e7-9598-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|92955660-5d8a-11e7-9598-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
| Regel 2.685: | Regel 2.689: | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"|NUTRIDRINK AARDBEI (code = '15132714' in codeSystem 'G-Standaard Artikel') | |style="background-color: white;"|NUTRIDRINK AARDBEI (code = '15132714' in codeSystem 'G-Standaard Artikel') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '710695' in codeSystem '2.16.840.1.113883.2.4.4.7') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verbruiksduur | |colspan="4"|Verbruiksduur | ||
| Regel 2.690: | Regel 2.697: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|92955660-5d8a-11e7-9598-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|92955660-5d8a-11e7-9598-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|}<section end=MVE_Sluis /> | |}<section end=MVE_Sluis /> | ||
| − | ==Patiënt | + | ==Patiënt Aaltje A. Adelaar== |
| − | <section begin= | + | <section begin=Adelaar /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Patiënt | ||
| Regel 2.702: | Regel 2.709: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Naamgegevens | |colspan="2"|Naamgegevens | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Aaltje A. Adelaar |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatienummer | |colspan="2"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999999011 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Geboortedatum | |colspan="2"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 jan 1950 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Geslacht | |colspan="2"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'AdministrativeGender') |
| − | |}<section end= | + | |}<section end=Adelaar /> |
| − | ===Toedieningsafspraken | + | ===Toedieningsafspraken Adelaar === |
| − | <section begin= | + | <section begin=TA_Adelaar /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | ||
| Regel 2.726: | Regel 2.733: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: white;"|gedurende | + | |style="background-color: white;"|gedurende 60 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
| Regel 2.743: | Regel 2.750: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|OXAZEPAM GF TABLET 10MG (code = '14243091' in codeSystem 'G-Standaard Artikel') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"|(code = ' | + | |style="background-color: white;"|(code = '1148753' in codeSystem '2.16.840.1.113883.2.4.4.7') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"|(code = ' | + | |style="background-color: white;"|(code = '1023' in codeSystem '2.16.840.1.113883.2.4.4.1') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"|gedurende | + | |style="background-color: white;"|gedurende 60 dagen, elke 4 dagen 2 stuks |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per 4 dagen 2 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|5ada2a80-100b-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
| − | |}<section end= | + | |}<section end=TA_Adelaar /> |
| − | ===Verstrekkingen | + | ===Verstrekkingen Adelaar === |
| − | <section begin= | + | <section begin=MVE_Adelaar /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekking | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekking | ||
| Regel 2.783: | Regel 2.781: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|5ada2a80-100b-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
| Regel 2.803: | Regel 2.801: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekte hoeveelheid | |colspan="4"|Verstrekte hoeveelheid | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|35 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|OXAZEPAM GF TABLET 10MG (code = '14243091' in codeSystem 'G-Standaard Artikel') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '1148753' in codeSystem '2.16.840.1.113883.2.4.4.7') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '1023' in codeSystem '2.16.840.1.113883.2.4.4.1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|5ada2a80-100b-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
| − | |}<section end= | + | |}<section end=MVE_Adelaar /> |
| − | ==Patiënt | + | ==Patiënt Peter P. Veenoord== |
| − | <section begin= | + | <section begin=Veenoord /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Patiënt | ||
| Regel 2.821: | Regel 2.825: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Naamgegevens | |colspan="2"|Naamgegevens | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Peter P. Veenoord |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatienummer | |colspan="2"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|555555021 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Geboortedatum | |colspan="2"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|20 jan 1950 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Geslacht | |colspan="2"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem 'AdministrativeGender') |
| − | |}<section end= | + | |}<section end=Veenoord /> |
| − | ===Toedieningsafspraken | + | ===Toedieningsafspraken Veenoord === |
| − | <section begin= | + | <section begin=TA_Veenoord /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | ||
| Regel 2.842: | Regel 2.846: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Afspraakdatum | |colspan="4"|Afspraakdatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T- 20 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: white;"|gedurende | + | |style="background-color: white;"|Vanaf T- 20 dagen, gedurende 30 dagen tot en met T+ 9 dagen, om 00:00 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
| Regel 2.862: | Regel 2.866: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Ibuprofen PCH tablet 600mg (code = '13550055' in codeSystem 'G-Standaard Artikel') |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"|gedurende | + | |style="background-color: white;"|Vanaf T- 20 dagen, gedurende 30 dagen tot en met T+ 9 dagen, om 00:00, 1 maal per dag 2 stuks |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"|1 maal per | + | |style="background-color: white;"|1 maal per dag 2 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|9b084780-9401-11e9-b475-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
| − | |} | + | |} |
| − | |||
| − | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 2.895: | Regel 2.888: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Afspraakdatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T- 100 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Gebruiksperiode |
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|Vanaf T- 100 dagen, gedurende 29 dagen tot en met T- 72 dagen, om 00:00 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
| Regel 2.915: | Regel 2.908: | ||
|style="background-color: white;"| | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Geneesmiddel - primaire code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XPRAEP SIROOP 2MG/ML (code = '12159220' in codeSystem 'G-Standaard Artikel') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '101079' in codeSystem '2.16.840.1.113883.2.4.4.7') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|Geneesmiddel - | + | |colspan="4"|Geneesmiddel - generiekere code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|(code = '10960' in codeSystem '2.16.840.1.113883.2.4.4.1') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|MBH identificatie | + | |rowspan="3"| |
| − | |style="background-color: white;"| | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | |}<section end= | + | |colspan="3"|Omschrijving |
| + | |style="background-color: white;"|Vanaf T- 100 dagen, gedurende 29 dagen tot en met T- 72 dagen, om 00:00, 1 maal per dag 10 ml | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Doseerinstructie | ||
| + | |style="background-color: white;"|1 maal per dag 10 ml | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MBH identificatie | ||
| + | |style="background-color: white;"|f77406a0-ef17-11e4-b80c-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| + | |} | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Afspraakdatum | ||
| + | |style="background-color: white;"|T- 50 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Gebruiksperiode | ||
| + | |style="background-color: white;"|Vanaf T- 50 dagen, gedurende 40 dagen tot en met T- 11 dagen, om 00:00 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Verstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="5"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Zorgaanbieder | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder identificatie nummer | ||
| + | |style="background-color: white;"|01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Organisatie naam | ||
| + | |style="background-color: white;"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|NUTRIDRINK AARDBEI NR16642 (code = '13659847' in codeSystem 'G-Standaard Artikel') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '710695' in codeSystem '2.16.840.1.113883.2.4.4.7') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Gebruiksinstructie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Omschrijving | ||
| + | |style="background-color: white;"|Vanaf T- 50 dagen, gedurende 40 dagen tot en met T- 11 dagen, om 00:00, 2 maal per dag 50 ml | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Doseerinstructie | ||
| + | |style="background-color: white;"|2 maal per dag 50 ml | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MBH identificatie | ||
| + | |style="background-color: white;"|fc93abe0-ef17-11e4-b80c-0800200ic9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| + | |} | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Afspraakdatum | ||
| + | |style="background-color: white;"|T- 10 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Gebruiksperiode | ||
| + | |style="background-color: white;"|Vanaf T- 10 dagen, gedurende 30 dagen tot en met T+ 19 dagen, om 00:00 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Verstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="5"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Zorgaanbieder | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder identificatie nummer | ||
| + | |style="background-color: white;"|01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Organisatie naam | ||
| + | |style="background-color: white;"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|ASPIRINE TABLET 100MG (code = '13849247' in codeSystem 'G-Standaard Artikel') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '202681' in codeSystem '2.16.840.1.113883.2.4.4.7') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '12548' in codeSystem '2.16.840.1.113883.2.4.4.1') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Gebruiksinstructie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Omschrijving | ||
| + | |style="background-color: white;"|Vanaf T- 10 dagen, gedurende 30 dagen tot en met T+ 19 dagen, om 00:00, 1 maal per 2 dagen 3 stuks zo nodig | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Doseerinstructie | ||
| + | |style="background-color: white;"|zo nodig 1 maal per 2 dagen 3 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MBH identificatie | ||
| + | |style="background-color: white;"|0443e710-ef18-11e4-b80c-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| + | |} | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Afspraakdatum | ||
| + | |style="background-color: white;"|T- 50 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Gebruiksperiode | ||
| + | |style="background-color: white;"|Vanaf T- 50 dagen, gedurende 7 dagen tot en met T- 44 dagen, om 00:00 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Verstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="5"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Zorgaanbieder | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder identificatie nummer | ||
| + | |style="background-color: white;"|01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Organisatie naam | ||
| + | |style="background-color: white;"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|ACENOCOUMAROL CF TABLET 1MG (code = '13918419' in codeSystem 'G-Standaard Artikel') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '856126' in codeSystem '2.16.840.1.113883.2.4.4.7') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '20303' in codeSystem '2.16.840.1.113883.2.4.4.1') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Gebruiksinstructie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Omschrijving | ||
| + | |style="background-color: white;"|Vanaf T- 50 dagen, gedurende 7 dagen tot en met T- 44 dagen, om 00:00, Gebruik bekend | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MBH identificatie | ||
| + | |style="background-color: white;"|08c37bc0-ef18-11e4-b80c-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| + | |} | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Afspraakdatum | ||
| + | |style="background-color: white;"|T- 5 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Gebruiksperiode | ||
| + | |style="background-color: white;"|Vanaf T- 5 dagen, gedurende 7 dagen tot en met T+ 1 dag, om 00:00 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Verstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="5"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Zorgaanbieder | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder identificatie nummer | ||
| + | |style="background-color: white;"|01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Organisatie naam | ||
| + | |style="background-color: white;"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|OXAZEPAM GF TABLET 10MG (code = '14243091' in codeSystem 'G-Standaard Artikel') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '1148753' in codeSystem '2.16.840.1.113883.2.4.4.7') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '1023' in codeSystem '2.16.840.1.113883.2.4.4.1') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Gebruiksinstructie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Omschrijving | ||
| + | |style="background-color: white;"|Vanaf T- 5 dagen, gedurende 7 dagen tot en met T+ 1 dag, om 00:00, 2 maal per dag 2 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Doseerinstructie | ||
| + | |style="background-color: white;"|2 maal per dag 2 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MBH identificatie | ||
| + | |style="background-color: white;"|0caac810-ef18-11e4-b80c-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| + | |}<section end=TA_Veenoord /> | ||
| + | ===Verstrekkingen Veenoord === | ||
| + | <section begin=MVE_Veenoord /> | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekking | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatie | ||
| + | |style="background-color: white;"|9b084780-9401-11e9-b475-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Aanschrijfdatum | ||
| + | |style="background-color: white;"|T- 20 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Verstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="5"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Zorgaanbieder | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder identificatie nummer | ||
| + | |style="background-color: white;"|01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Organisatie naam | ||
| + | |style="background-color: white;"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Verstrekte hoeveelheid | ||
| + | |style="background-color: white;"|60 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|Ibuprofen PCH tablet 600mg (code = '13550055' in codeSystem 'G-Standaard Artikel') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MBH identificatie | ||
| + | |style="background-color: white;"|9b084780-9401-11e9-b475-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| + | |} | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekking | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatie | ||
| + | |style="background-color: white;"|f77406a0-ef17-11e4-b80c-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Aanschrijfdatum | ||
| + | |style="background-color: white;"|T- 100 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Verstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="5"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Zorgaanbieder | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder identificatie nummer | ||
| + | |style="background-color: white;"|01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Organisatie naam | ||
| + | |style="background-color: white;"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Verstrekte hoeveelheid | ||
| + | |style="background-color: white;"|290 ml | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|XPRAEP SIROOP 2MG/ML (code = '12159220' in codeSystem 'G-Standaard Artikel') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '101079' in codeSystem '2.16.840.1.113883.2.4.4.7') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '10960' in codeSystem '2.16.840.1.113883.2.4.4.1') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MBH identificatie | ||
| + | |style="background-color: white;"|f77406a0-ef17-11e4-b80c-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| + | |} | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekking | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatie | ||
| + | |style="background-color: white;"|fc93abe0-ef17-11e4-b80c-0800200ic9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Aanschrijfdatum | ||
| + | |style="background-color: white;"|T- 50 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Verstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="5"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Zorgaanbieder | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder identificatie nummer | ||
| + | |style="background-color: white;"|01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Organisatie naam | ||
| + | |style="background-color: white;"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Verstrekte hoeveelheid | ||
| + | |style="background-color: white;"|4000 ml | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|NUTRIDRINK AARDBEI NR16642 (code = '13659847' in codeSystem 'G-Standaard Artikel') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '710695' in codeSystem '2.16.840.1.113883.2.4.4.7') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MBH identificatie | ||
| + | |style="background-color: white;"|fc93abe0-ef17-11e4-b80c-0800200ic9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| + | |} | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekking | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatie | ||
| + | |style="background-color: white;"|0443e710-ef18-11e4-b80c-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Aanschrijfdatum | ||
| + | |style="background-color: white;"|T- 10 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Verstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="5"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Zorgaanbieder | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder identificatie nummer | ||
| + | |style="background-color: white;"|01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Organisatie naam | ||
| + | |style="background-color: white;"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Verstrekte hoeveelheid | ||
| + | |style="background-color: white;"|30 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|ASPIRINE TABLET 100MG (code = '13849247' in codeSystem 'G-Standaard Artikel') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '202681' in codeSystem '2.16.840.1.113883.2.4.4.7') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '12548' in codeSystem '2.16.840.1.113883.2.4.4.1') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MBH identificatie | ||
| + | |style="background-color: white;"|0443e710-ef18-11e4-b80c-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| + | |} | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekking | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatie | ||
| + | |style="background-color: white;"|08c37bc0-ef18-11e4-b80c-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Aanschrijfdatum | ||
| + | |style="background-color: white;"|T- 50 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Verstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="5"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Zorgaanbieder | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder identificatie nummer | ||
| + | |style="background-color: white;"|01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Organisatie naam | ||
| + | |style="background-color: white;"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Verstrekte hoeveelheid | ||
| + | |style="background-color: white;"|14 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|ACENOCOUMAROL CF TABLET 1MG (code = '13918419' in codeSystem 'G-Standaard Artikel') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '856126' in codeSystem '2.16.840.1.113883.2.4.4.7') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '20303' in codeSystem '2.16.840.1.113883.2.4.4.1') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MBH identificatie | ||
| + | |style="background-color: white;"|08c37bc0-ef18-11e4-b80c-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| + | |} | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekking | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatie | ||
| + | |style="background-color: white;"|0caac810-ef18-11e4-b80c-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Aanschrijfdatum | ||
| + | |style="background-color: white;"|T- 5 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Verstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="5"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Zorgaanbieder | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder identificatie nummer | ||
| + | |style="background-color: white;"|01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Organisatie naam | ||
| + | |style="background-color: white;"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Verstrekte hoeveelheid | ||
| + | |style="background-color: white;"|35 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|OXAZEPAM GF TABLET 10MG (code = '14243091' in codeSystem 'G-Standaard Artikel') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '1148753' in codeSystem '2.16.840.1.113883.2.4.4.7') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|(code = '1023' in codeSystem '2.16.840.1.113883.2.4.4.1') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MBH identificatie | ||
| + | |style="background-color: white;"|0caac810-ef18-11e4-b80c-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| + | |}<section end=MVE_Veenoord /> | ||
[[Categorie:Kwalificatie]] | [[Categorie:Kwalificatie]] | ||
Huidige versie van 20 jul 2020 om 01:11
1 Addenda voor inhoudelijke gegevens
1.1 Patiënt Richard R. van Henegouwen
| Patiënt | ||
| Gegevenselement | Waarde | |
| Naamgegevens | Richard R. van Henegouwen | |
| Identificatienummer | 555555112 [BSN] | |
| Geboortedatum | 20 feb 1950 | |
| Geslacht | Man (code = 'M' in codeSystem 'AdministrativeGender') | |
1.1.1 Toedieningsafspraken Henegouwen
| Toedieningsafspraak | ||||
| Gegevenselement | Waarde | |||
| Afspraakdatum | T | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Geneesmiddel - primaire code | MEBENDAZOL SAN TABLET 100MG (code = '14234785' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '1046764' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Geneesmiddel - generiekere code | (code = '9954' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
| Gebruiksinstructie | ||||
| Omschrijving | tot nader order, gebruik bekend | |||
| MBH identificatie | 38129f10-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
1.1.2 Verstrekkingen Henegouwen
| Verstrekking | ||||
| Gegevenselement | Waarde | |||
| Identificatie | 38129f10-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Aanschrijfdatum | T | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Verstrekte hoeveelheid | 2 stuks | |||
| Geneesmiddel - primaire code | MEBENDAZOL SAN TABLET 100MG (code = '14234785' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '1046764' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Geneesmiddel - generiekere code | (code = '9954' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
| MBH identificatie | 38129f10-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
1.2 Patiënt Carel C. Creiens
| Patiënt | ||
| Gegevenselement | Waarde | |
| Naamgegevens | Carel C. Creiens | |
| Identificatienummer | 999999060 [BSN] | |
| Geboortedatum | 1 jun 1950 | |
| Geslacht | Man (code = 'M' in codeSystem 'AdministrativeGender') | |
1.2.1 Toedieningsafspraken Creiens
| Toedieningsafspraak | ||||
| Gegevenselement | Waarde | |||
| Afspraakdatum | T- 500 dagen | |||
| Gebruiksperiode | gedurende 7 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Geneesmiddel - primaire code | VERAPAMIL HCL CF TABLET 40MG (code = '14303841' in codeSystem 'G-Standaard Artikel') | |||
| Gebruiksinstructie | ||||
| Omschrijving | gedurende 7 dagen, 4 maal per dag 1 tablet | |||
| Doseerinstructie | 4 maal per dag 1 stuk | |||
| MBH identificatie | 1f5eebe0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Toedieningsafspraak | ||||
| Gegevenselement | Waarde | |||
| Afspraakdatum | T- 635 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Geneesmiddel - primaire code | ORS POEDER SACHET 5,4G SAN (code = '14565277' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '1417762' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Gebruiksinstructie | ||||
| Omschrijving | tot nader order, 3 maal per dag 1 zakje | |||
| Doseerinstructie | 3 maal per dag 1 stuk | |||
| MBH identificatie | 47f39010-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Toedieningsafspraak | ||||
| Gegevenselement | Waarde | |||
| Afspraakdatum | T- 310 dagen | |||
| Gebruiksperiode | gedurende 1826 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Geneesmiddel - primaire code | PROLIA 60 INJVLST 60MG/ML WWSP 1ML (code = '15654486' in codeSystem 'G-Standaard Artikel') | |||
| Gebruiksinstructie | ||||
| Omschrijving | gedurende 1826 dagen, 2 maal per jaar 1 injectie | |||
| Doseerinstructie | 2 maal per jaar 1 stuk | |||
| MBH identificatie | 4d5128b0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Toedieningsafspraak | ||||
| Gegevenselement | Waarde | |||
| Afspraakdatum | T- 175 dagen | |||
| Gebruiksperiode | gedurende 60 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Geneesmiddel - primaire code | IBUPROFEN PCH TABLET 200MG CLICKER (code = '14765233' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '719374' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Geneesmiddel - generiekere code | (code = '50997' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
| Gebruiksinstructie | ||||
| Omschrijving | gedurende 60 dagen, 1 maal per dag een kwart tablet | |||
| Doseerinstructie | 1 maal per dag 0.25 stuk | |||
| MBH identificatie | 52c41e10-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Toedieningsafspraak | ||||
| Gegevenselement | Waarde | |||
| Afspraakdatum | T- 144 dagen | |||
| Gebruiksperiode | gedurende 21 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Geneesmiddel - primaire code | KENACORT A 40 INJECTIESUSPENSIE 40MG/ML FLACON 5ML (code = '12128198' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '219584' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Geneesmiddel - generiekere code | (code = '120219' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
| Gebruiksinstructie | ||||
| Omschrijving | gedurende 21 dagen, 1 maal per week 15 ml | |||
| Doseerinstructie | 1 maal per week 15 ml | |||
| MBH identificatie | 59df4530-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Toedieningsafspraak | ||||
| Gegevenselement | Waarde | |||
| Afspraakdatum | T- 652 dagen | |||
| Gebruiksperiode | Vanaf T- 650 dagen, gedurende 7 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Geneesmiddel - primaire code | TRUSOPT OOGDRUPPELS 20MG/ML FLACON 5ML (code = '13906550' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '850144' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Geneesmiddel - generiekere code | (code = '95575' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T- 650 dagen, gedurende 7 dagen, 2 maal per dag 1 druppel | |||
| Doseerinstructie | 2 maal per dag 1 druppel | |||
| MBH identificatie | 5ed2f870-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Toedieningsafspraak | ||||
| Gegevenselement | Waarde | |||
| Afspraakdatum | T- 287 dagen | |||
| Gebruiksperiode | Vanaf T- 287 dagen, tot nader order | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Geneesmiddel - primaire code | RESONIUM A POEDER (code = '13650203' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '15261' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Geneesmiddel - generiekere code | (code = '121363' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T- 287 dagen, tot nader order, 2 maal per dag 5 gram | |||
| Doseerinstructie | 2 maal per dag 5 gram | |||
| MBH identificatie | 63c23ee0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Toedieningsafspraak | ||||
| Gegevenselement | Waarde | |||
| Afspraakdatum | T- 71 dagen | |||
| Gebruiksperiode | Vanaf T- 71 dagen, tot en met T+ 149 dagen, om 23:59 | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Geneesmiddel - primaire code | SEREVENT DISKUS INHPDR 50MCG 60DO (code = '14039303' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '1029746' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Geneesmiddel - generiekere code | (code = '87424' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T- 71 dagen, tot en met T+ 149 dagen, om 23:59, 2 maal per dag 2 inhalaties | |||
| Doseerinstructie | 2 maal per dag 2 doses | |||
| MBH identificatie | 6898f440-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Toedieningsafspraak | ||||
| Gegevenselement | Waarde | |||
| Afspraakdatum | T- 10 dagen | |||
| Gebruiksperiode | gedurende 18 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Geneesmiddel - primaire code | DUROGESIC 100 MATRIXPLEISTER 16,8MG (code = '13878956' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '836982' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Geneesmiddel - generiekere code | (code = '122033' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
| Gebruiksinstructie | ||||
| Omschrijving | gedurende 18 dagen, 1 maal per 3 dagen 2 pleisters | |||
| Doseerinstructie | 1 maal per 3 dagen 2 stuks | |||
| MBH identificatie | 6da7a990-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Toedieningsafspraak | ||||
| Gegevenselement | Waarde | |||
| Afspraakdatum | T | |||
| Gebruiksperiode | gedurende 30 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Geneesmiddel - primaire code | Carvedilol CF tablet 6,25mg (code = '14933349' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | CARVEDILOL TABLET 6,25MG (code = '101451' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | gedurende 30 dagen, gebruik volgens afspraak | |||
| MBH identificatie | 721def70-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Toedieningsafspraak | ||||
| Gegevenselement | Waarde | |||
| Afspraakdatum | T | |||
| Gebruiksperiode | Vanaf T, tot en met T+ 42 dagen, om 00:00 | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Geneesmiddel - primaire code | Diazepam PCH tablet 5mg (code = '13908790' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | Diazepam tablet 5mg (code = '20664' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T, tot en met T+ 42 dagen, om 00:00, eerst 1 week 6 stuks per dag; vanaf T + 1wk, gedurende 1 week 5 stuks per dag; vanaf T + 2 weken, gedurende 1 week 4 stuks per dag; vanaf T + 3 weken, gedurende 1 week 3 stuks per dag; vanaf T + 4 weken, gedurende 1 week 2 stuks per dag; vanaf T + 5 weken, gedurende 1 week 1 stuks per dag | |||
| MBH identificatie | 78074d50-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
1.2.2 Verstrekkingen Creiens
| Verstrekking | ||||
| Gegevenselement | Waarde | |||
| Identificatie | 1f5eebe0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Aanschrijfdatum | T- 500 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Verstrekte hoeveelheid | 30 stuks | |||
| Geneesmiddel - primaire code | VERAPAMIL HCL CF TABLET 40MG (code = '14303841' in codeSystem 'G-Standaard Artikel') | |||
| MBH identificatie | 1f5eebe0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Verstrekking | ||||
| Gegevenselement | Waarde | |||
| Identificatie | 47f39010-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Aanschrijfdatum | T- 635 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Verstrekte hoeveelheid | 30 stuks | |||
| Geneesmiddel - primaire code | ORS POEDER SACHET 5,4G SAN (code = '14565277' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '1417762' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Verbruiksduur | 10 dagen | |||
| MBH identificatie | 47f39010-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Verstrekking | ||||
| Gegevenselement | Waarde | |||
| Identificatie | 4d5128b0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Aanschrijfdatum | T- 310 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Verstrekte hoeveelheid | 10 stuks | |||
| Geneesmiddel - primaire code | PROLIA 60 INJVLST 60MG/ML WWSP 1ML (code = '15654486' in codeSystem 'G-Standaard Artikel') | |||
| Verbruiksduur | 5 jaar | |||
| MBH identificatie | 4d5128b0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Verstrekking | ||||
| Gegevenselement | Waarde | |||
| Identificatie | 52c41e10-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Aanschrijfdatum | T- 175 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Verstrekte hoeveelheid | 6 stuks | |||
| Geneesmiddel - primaire code | IBUPROFEN PCH TABLET 200MG CLICKER (code = '14765233' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '719374' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Geneesmiddel - generiekere code | (code = '50997' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
| Verbruiksduur | 24 dagen | |||
| MBH identificatie | 52c41e10-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Verstrekking | ||||
| Gegevenselement | Waarde | |||
| Identificatie | 59df4530-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Aanschrijfdatum | T- 144 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Verstrekte hoeveelheid | 10 stuks | |||
| Geneesmiddel - primaire code | KENACORT A 40 INJECTIESUSPENSIE 40MG/ML FLACON 5ML (code = '12128198' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '219584' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Geneesmiddel - generiekere code | (code = '120219' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
| MBH identificatie | 59df4530-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Verstrekking | ||||
| Gegevenselement | Waarde | |||
| Identificatie | 5ed2f870-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Aanschrijfdatum | T- 652 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Verstrekte hoeveelheid | 1 stuk | |||
| Geneesmiddel - primaire code | TRUSOPT OOGDRUPPELS 20MG/ML FLACON 5ML (code = '13906550' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '850144' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Geneesmiddel - generiekere code | (code = '95575' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
| MBH identificatie | 5ed2f870-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Verstrekking | ||||
| Gegevenselement | Waarde | |||
| Identificatie | 63c23ee0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Aanschrijfdatum | T- 287 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Verstrekte hoeveelheid | 10 gram | |||
| Geneesmiddel - primaire code | RESONIUM A POEDER (code = '13650203' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '15261' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Geneesmiddel - generiekere code | (code = '121363' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
| MBH identificatie | 63c23ee0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Verstrekking | ||||
| Gegevenselement | Waarde | |||
| Identificatie | 6898f440-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Aanschrijfdatum | T- 71 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Verstrekte hoeveelheid | 10 stuks | |||
| Geneesmiddel - primaire code | SEREVENT DISKUS INHPDR 50MCG 60DO (code = '14039303' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '1029746' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Geneesmiddel - generiekere code | (code = '87424' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
| MBH identificatie | 6898f440-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Verstrekking | ||||
| Gegevenselement | Waarde | |||
| Identificatie | 6da7a990-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Aanschrijfdatum | T- 10 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Verstrekte hoeveelheid | 12 stuks | |||
| Geneesmiddel - primaire code | DUROGESIC 100 MATRIXPLEISTER 16,8MG (code = '13878956' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '836982' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Geneesmiddel - generiekere code | (code = '122033' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
| MBH identificatie | 6da7a990-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Verstrekking | ||||
| Gegevenselement | Waarde | |||
| Identificatie | 721def70-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Aanschrijfdatum | T | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Verstrekte hoeveelheid | 60 stuks | |||
| Geneesmiddel - primaire code | Carvedilol CF tablet 6,25mg (code = '14933349' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | CARVEDILOL TABLET 6,25MG (code = '101451' in codeSystem 'G-Standaard GPK') | |||
| MBH identificatie | 721def70-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Verstrekking | ||||
| Gegevenselement | Waarde | |||
| Identificatie | 78074d50-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Aanschrijfdatum | T | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Verstrekte hoeveelheid | 180 stuks | |||
| Geneesmiddel - primaire code | Diazepam PCH tablet 5mg (code = '13908790' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | Diazepam tablet 5mg (code = '20664' in codeSystem 'G-Standaard GPK') | |||
| MBH identificatie | 78074d50-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
1.3 Patiënt Aygül A. Direnç
| Patiënt | ||
| Gegevenselement | Waarde | |
| Naamgegevens | Aygül A. Direnç | |
| Identificatienummer | 555555914 [BSN] | |
| Geboortedatum | 20 may 1950 | |
| Geslacht | Man (code = 'M' in codeSystem 'AdministrativeGender') | |
1.3.1 Toedieningsafspraken Direnç
| Toedieningsafspraak | ||||
| Gegevenselement | Waarde | |||
| Afspraakdatum | T- 566 dagen | |||
| Gebruiksperiode | gedurende 50 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Geneesmiddel - primaire code | NOVORAPID PENFILL INJVLST 100E/ML PATROON 3ML (code = '14305054' in codeSystem 'G-Standaard Artikelnummer') | |||
| Gebruiksinstructie | ||||
| Omschrijving | gedurende 50 dagen, 3x per dag 8 tot 10 eenheid | |||
| Doseerinstructie | 3 maal per dag 8 à 10 eenheid | |||
| MBH identificatie | d4d03380-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Toedieningsafspraak | ||||
| Gegevenselement | Waarde | |||
| Afspraakdatum | T- 613 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Geneesmiddel - primaire code | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '14165635' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '1110837' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Geneesmiddel - generiekere code | (code = '103039' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
| Gebruiksinstructie | ||||
| Omschrijving | tot nader order, 1 tot 2 maal per dag 1 tablet | |||
| Doseerinstructie | 1 à 2 maal per dag 1 stuk | |||
| MBH identificatie | 9b4c3b90-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Toedieningsafspraak | ||||
| Gegevenselement | Waarde | |||
| Afspraakdatum | T- 252 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Geneesmiddel - primaire code | Cetomacrogolcreme met 10% vaseline fagron (code = '14344491' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | tot nader order, 1 tot 3 keer per dag aanbrengen | |||
| Aanvullende instructie | aanbrengen (code = '1018' in codeSystem '2.16.840.1.113883.2.4.4.5') | |||
| Doseerinstructie | 1 à 3 maal per dag | |||
| MBH identificatie | a378f9c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Toedieningsafspraak | ||||
| Gegevenselement | Waarde | |||
| Afspraakdatum | T- 217 dagen | |||
| Gebruiksperiode | gedurende 90 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Geneesmiddel - primaire code | SPIRIVA INHALPDR 18 MCG (code = '14750406' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '1476866' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Geneesmiddel - generiekere code | (code = '115371' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
| Gebruiksinstructie | ||||
| Omschrijving | gedurende 90 dagen, per 2 dagen 1 inhalatie | |||
| Doseerinstructie | 1 maal per 2 dagen 1 dosis | |||
| MBH identificatie | a7e331b0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Toedieningsafspraak | ||||
| Gegevenselement | Waarde | |||
| Afspraakdatum | T- 234 dagen | |||
| Gebruiksperiode | gedurende 168 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Geneesmiddel - primaire code | Marvelon tablet (code = '12323047' in codeSystem 'G-Standaard Artikel') | |||
| Gebruiksinstructie | ||||
| Omschrijving | gedurende 168 dagen, Cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet | |||
| Doseerinstructie | gedurende 21 dagen 1 maal per dag | |||
| Herhaalperiode cyclisch schema | 28 dagen | |||
| MBH identificatie | ac8c4760-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Toedieningsafspraak | ||||
| Gegevenselement | Waarde | |||
| Afspraakdatum | T- 234 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Geneesmiddel - primaire code | METFORMINE HCL CF TABLET 850MG (code = '15061078' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '1037137' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Geneesmiddel - generiekere code | (code = '15865' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
| Gebruiksinstructie | ||||
| Omschrijving | tot nader order, 1 tot 3 maal per week 1 tot 2 tabletten | |||
| Doseerinstructie | 1 à 3 maal per week 1 à 2 stuks | |||
| MBH identificatie | b1730250-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Toedieningsafspraak | ||||
| Gegevenselement | Waarde | |||
| Afspraakdatum | T- 31 dagen | |||
| Gebruiksperiode | gedurende 60 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Geneesmiddel - primaire code | INSULATARD PENFILL INJ 100IE/ML PATR 3ML (code = '14815982' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '709085' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Geneesmiddel - generiekere code | (code = '111325' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
| Gebruiksinstructie | ||||
| Omschrijving | gedurende 60 dagen, Elke dag om 8:00, 14:00 en 20:00 uur 16IE | |||
| Doseerinstructie | elke dag om 08:00, 14:00 en 20:00 16 internat.eenh. | |||
| MBH identificatie | b6d9e9c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Toedieningsafspraak | ||||
| Gegevenselement | Waarde | |||
| Afspraakdatum | T | |||
| Gebruiksperiode | Vanaf T, om 15:48, gedurende 5 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Geneesmiddel - primaire code | FLUIMUCIL INHVLST 100MG/ML AMPUL 4ML (code = '13966383' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '888567' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Geneesmiddel - generiekere code | (code = '38539' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T, om 15:48, gedurende 5 dagen, 2 maal per dag 4 milliliter, eerst oplossen in water, mond spoelen, daarna uitspugen | |||
| Aanvullende instructie | Eerst oplossen in water (code = '27' in codeSystem '2.16.840.1.113883.2.4.4.5') | |||
| Aanvullende instructie | Mond spoelen, daarna uitspugen (code = '69' in codeSystem '2.16.840.1.113883.2.4.4.5') | |||
| Doseerinstructie | 2 maal per dag 4 ml | |||
| MBH identificatie | bb7ee0c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Toedieningsafspraak | ||||
| Gegevenselement | Waarde | |||
| Afspraakdatum | T | |||
| Gebruiksperiode | Vanaf T, tot en met T+ 27 dagen, om 00:00 | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Geneesmiddel - primaire code | AFFUSINE CREME 20MG/G (code = '15838234' in codeSystem 'G-Standaard Artikel') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T, tot en met T+ 27 dagen, om 00:00, Eerst, gedurende 2 weken, 3 gram per dag dun aanbrengen; daarna, gedurende 3 weken, 2 gram per dag dun aanbrengen ; daarna, gedurende 6 dagen, 1 gram per dag dun aanbrengen | |||
| Aanvullende instructie | dun aanbrengen overig (code = 'OTH' in codeSystem '2.16.840.1.113883.5.1008') | |||
| MBH identificatie | c635f350-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Toedieningsafspraak | ||||
| Gegevenselement | Waarde | |||
| Afspraakdatum | T | |||
| Gebruiksperiode | gedurende 48 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Geneesmiddel - primaire code | Ibuprofen PCH tablet 600mg (code = '13550055' in codeSystem 'G-Standaard HPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | gedurende 48 dagen, 2x per dag 1/4 tablet | |||
| Doseerinstructie | 2 maal per dag 0.25 stuk | |||
| MBH identificatie | cbb37000-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Toedieningsafspraak | ||||
| Gegevenselement | Waarde | |||
| Afspraakdatum | T | |||
| Gebruiksperiode | gedurende 10 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM SANDOZ TABLET MSR 50MG (code = '14279762' in codeSystem 'G-Standaard HPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | gedurende 10 dagen, DAGDOSIS: 3 stuks per dag | |||
| MBH identificatie | fbaecc50-4bec-11e5-b970-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
1.3.2 Verstrekkingen Direnç
| Verstrekking | ||||
| Gegevenselement | Waarde | |||
| Identificatie | d4d03380-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Aanschrijfdatum | T- 566 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Verstrekte hoeveelheid | 5 stuks | |||
| Geneesmiddel - primaire code | NOVORAPID PENFILL INJVLST 100E/ML PATROON 3ML (code = '14305054' in codeSystem 'G-Standaard Artikelnummer') | |||
| MBH identificatie | d4d03380-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Verstrekking | ||||
| Gegevenselement | Waarde | |||
| Identificatie | 9b4c3b90-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Aanschrijfdatum | T- 613 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Verstrekte hoeveelheid | 120 stuks | |||
| Geneesmiddel - primaire code | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '14165635' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '1110837' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Geneesmiddel - generiekere code | (code = '103039' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
| MBH identificatie | 9b4c3b90-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Verstrekking | ||||
| Gegevenselement | Waarde | |||
| Identificatie | a378f9c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Aanschrijfdatum | T- 252 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Verstrekte hoeveelheid | 60 gram | |||
| Geneesmiddel - primaire code | Cetomacrogolcreme met 10% vaseline fagron (code = '14344491' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-Standaard GPK') | |||
| MBH identificatie | a378f9c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Verstrekking | ||||
| Gegevenselement | Waarde | |||
| Identificatie | a7e331b0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Aanschrijfdatum | T- 217 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Verstrekte hoeveelheid | 30 stuks | |||
| Geneesmiddel - primaire code | SPIRIVA INHALPDR 18 MCG (code = '14750406' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '1476866' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Geneesmiddel - generiekere code | (code = '115371' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
| MBH identificatie | a7e331b0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Verstrekking | ||||
| Gegevenselement | Waarde | |||
| Identificatie | ac8c4760-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Aanschrijfdatum | T- 234 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Verstrekte hoeveelheid | 126 stuks | |||
| Geneesmiddel - primaire code | Marvelon tablet (code = '12323047' in codeSystem 'G-Standaard Artikel') | |||
| Verbruiksduur | 24 weken | |||
| MBH identificatie | ac8c4760-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Verstrekking | ||||
| Gegevenselement | Waarde | |||
| Identificatie | b1730250-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Aanschrijfdatum | T- 234 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Verstrekte hoeveelheid | 21 stuks | |||
| Geneesmiddel - primaire code | METFORMINE HCL CF TABLET 850MG (code = '15061078' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '1037137' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Geneesmiddel - generiekere code | (code = '15865' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
| Verbruiksduur | 21 weken | |||
| MBH identificatie | b1730250-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Verstrekking | ||||
| Gegevenselement | Waarde | |||
| Identificatie | b6d9e9c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Aanschrijfdatum | T- 31 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Verstrekte hoeveelheid | 1 stuk | |||
| Geneesmiddel - primaire code | INSULATARD PENFILL INJ 100IE/ML PATR 3ML (code = '14815982' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '709085' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Geneesmiddel - generiekere code | (code = '111325' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
| MBH identificatie | b6d9e9c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Verstrekking | ||||
| Gegevenselement | Waarde | |||
| Identificatie | bb7ee0c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Aanschrijfdatum | T- 31 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Verstrekte hoeveelheid | 10 stuks | |||
| Geneesmiddel - primaire code | FLUIMUCIL INHVLST 100MG/ML AMPUL 4ML (code = '13966383' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '888567' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Geneesmiddel - generiekere code | (code = '38539' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
| MBH identificatie | bb7ee0c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Verstrekking | ||||
| Gegevenselement | Waarde | |||
| Identificatie | c635f350-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Aanschrijfdatum | T | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Verstrekte hoeveelheid | 90 gram | |||
| Geneesmiddel - primaire code | AFFUSINE CREME 20MG/G (code = '15838234' in codeSystem 'G-Standaard Artikel') | |||
| Verbruiksduur | 41 dagen | |||
| MBH identificatie | c635f350-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Verstrekking | ||||
| Gegevenselement | Waarde | |||
| Identificatie | cbb37000-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Aanschrijfdatum | T | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Verstrekte hoeveelheid | 24 stuks | |||
| Geneesmiddel - primaire code | Ibuprofen PCH tablet 600mg (code = '13550055' in codeSystem 'G-Standaard HPK') | |||
| MBH identificatie | cbb37000-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Verstrekking | ||||
| Gegevenselement | Waarde | |||
| Identificatie | fbaecc50-4bec-11e5-b970-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Aanschrijfdatum | T | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Verstrekte hoeveelheid | 30 stuks | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM SANDOZ TABLET MSR 50MG (code = '14279762' in codeSystem 'G-Standaard HPK') | |||
| MBH identificatie | fbaecc50-4bec-11e5-b970-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
1.4 Patiënt Hanneke XXX_Bekker
| Patiënt | ||
| Gegevenselement | Waarde | |
| Naamgegevens | Hanneke XXX_Bekker | |
| Identificatienummer | 999911715 [BSN] | |
| Geboortedatum | 2 aug 1964 | |
| Geslacht | Vrouw (code = 'F' in codeSystem 'AdministrativeGender') | |
1.4.1 Toedieningsafspraken XXX_Bekker
| Toedieningsafspraak | ||||
| Gegevenselement | Waarde | |||
| Afspraakdatum | T- 100 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Geneesmiddel - primaire code | PARACETAMOL PCH TABLET 500MG (code = '15401367' in codeSystem 'G-Standaard Artikelnummer') | |||
| Gebruiksinstructie | ||||
| Omschrijving | tot nader order, Zo nodig bij pijn, maximaal 6 stuks per dag | |||
| Doseerinstructie | zo nodig bij pijn , maximaal 6 stuks per dag | |||
| MBH identificatie | 14606290-2dbd-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Toedieningsafspraak | ||||
| Gegevenselement | Waarde | |||
| Afspraakdatum | T- 107 dagen | |||
| Gebruiksperiode | gedurende 7 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Geneesmiddel - primaire code | PARACETAMOL PCH TABLET 500MG (code = '15401367' in codeSystem 'G-Standaard Artikelnummer') | |||
| Gebruiksinstructie | ||||
| Omschrijving | gedurende 7 dagen, Gedurende 7 dagen, 1 keer per 4 uur 1 stuk | |||
| Doseerinstructie | 1 maal per 4 uur 1 stuk | |||
| MBH identificatie | 13438b70-2dbe-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Toedieningsafspraak | ||||
| Gegevenselement | Waarde | |||
| Afspraakdatum | T | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Geneesmiddel - Product specificatie | ||||
| Product naam | Ureum 10% in eucerine cum aqua | |||
| Omschrijving | Titel: Ureum 10% in eucerine cum aqua
Regel: Ureum 10 gr Regel: Eucerine met water creme FNA ad 100g. | |||
| Ingredient | ||||
| Ingredient code | UREUM (code = '15219127' in codeSystem '2.16.840.1.113883.2.4.4.8') | |||
| Sterkte | 10 gram per 100 gram | |||
| Ingredient | ||||
| Ingredient code | EUCERINE MET WATER FAGRON (code = '14740877' in codeSystem '2.16.840.1.113883.2.4.4.8') | |||
| Sterkte | voldoende hoeveelheid per 100 gram | |||
| Gebruiksinstructie | ||||
| Omschrijving | tot nader order, Zo nodig | |||
| Doseerinstructie | zo nodig | |||
| MBH identificatie | a083ca80-5772-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
1.4.2 Verstrekkingen XXX_Bekker
| Verstrekking | ||||
| Gegevenselement | Waarde | |||
| Identificatie | 14606290-2dbd-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Aanschrijfdatum | T- 100 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Verstrekte hoeveelheid | 20 stuks | |||
| Geneesmiddel - primaire code | PARACETAMOL PCH TABLET 500MG (code = '15401367' in codeSystem 'G-Standaard Artikelnummer') | |||
| MBH identificatie | 14606290-2dbd-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Verstrekking | ||||
| Gegevenselement | Waarde | |||
| Identificatie | 13438b70-2dbe-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Aanschrijfdatum | T- 107 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Verstrekte hoeveelheid | 40 stuks | |||
| Geneesmiddel - primaire code | PARACETAMOL PCH TABLET 500MG (code = '15401367' in codeSystem 'G-Standaard Artikelnummer') | |||
| MBH identificatie | 13438b70-2dbe-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Verstrekking | ||||
| Gegevenselement | Waarde | |||
| Identificatie | a083ca80-5772-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Aanschrijfdatum | T | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Verstrekte hoeveelheid | 100 gram | |||
| Geneesmiddel - Product specificatie | ||||
| Product naam | Ureum 10% in eucerine cum aqua | |||
| Omschrijving | Titel: Ureum 10% in eucerine cum aqua
Regel: Ureum 10 gr
Regel: Eucerine met water creme FNA ad 100g.
| |||
| Ingredient | ||||
| Ingredient code | UREUM (code = '15219127' in codeSystem '2.16.840.1.113883.2.4.4.8') | |||
| Sterkte | 10 gram per 100 gram | |||
| Ingredient | ||||
| Ingredient code | EUCERINE MET WATER FAGRON (code = '14740877' in codeSystem '2.16.840.1.113883.2.4.4.8') | |||
| Sterkte | voldoende hoeveelheid per 100 gram | |||
| MBH identificatie | a083ca80-5772-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
1.5 Patiënt Brooke B. van der Berken
| Patiënt | ||
| Gegevenselement | Waarde | |
| Naamgegevens | Brooke B. van der Berken | |
| Identificatienummer | 999999059 [BSN] | |
| Geboortedatum | 1 may 1950 | |
| Geslacht | Vrouw (code = 'F' in codeSystem 'AdministrativeGender') | |
1.5.1 Toedieningsafspraken Berken
| Toedieningsafspraak | ||||
| Gegevenselement | Waarde | |||
| Afspraakdatum | T- 93 dagen | |||
| Gebruiksperiode | gedurende 40 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Geneesmiddel - primaire code | NUTRIDRINK AARDBEI NR16642 (code = '13659847' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '710695' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Gebruiksinstructie | ||||
| Omschrijving | gedurende 40 dagen, 3 maal per dag 1 Eetlepel (= 15ml) | |||
| Doseerinstructie | 3 maal per dag 15 ml | |||
| MBH identificatie | e22b15e0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
1.5.2 Verstrekkingen Berken
| Verstrekking | ||||
| Gegevenselement | Waarde | |||
| Identificatie | e22b15e0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Aanschrijfdatum | T- 93 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Verstrekte hoeveelheid | 2000 ml | |||
| Geneesmiddel - primaire code | NUTRIDRINK AARDBEI NR16642 (code = '13659847' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '710695' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Verbruiksduur | 44 dagen | |||
| MBH identificatie | e22b15e0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
1.6 Patiënt B. B. van der Sluis
| Patiënt | ||
| Gegevenselement | Waarde | |
| Naamgegevens | B. B. van der Sluis | |
| Identificatienummer | 999911545 [BSN] | |
| Geboortedatum | 2 aug 1964 | |
| Geslacht | Vrouw (code = 'F' in codeSystem 'AdministrativeGender') | |
1.6.1 Toedieningsafspraken Sluis
| Toedieningsafspraak | ||||
| Gegevenselement | Waarde | |||
| Afspraakdatum | T- 43 dagen, om 12:45 | |||
| Gebruiksperiode | gedurende 30 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Geneesmiddel - primaire code | NUTRIDRINK AARDBEI (code = '15132714' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '710695' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Gebruiksinstructie | ||||
| Omschrijving | gedurende 30 dagen, 3 maal per dag 1 Eetlepel (= 15ml) | |||
| Doseerinstructie | 3 maal per dag 15 ml | |||
| MBH identificatie | 84bd06a0-5d8a-11e7-9598-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Toedieningsafspraak | ||||
| Gegevenselement | Waarde | |||
| Afspraakdatum | T- 93 dagen, om 12:00 | |||
| Gebruiksperiode | gedurende 30 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Geneesmiddel - primaire code | NUTRIDRINK AARDBEI (code = '15132714' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '710695' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Gebruiksinstructie | ||||
| Omschrijving | gedurende 30 dagen, 3 maal per dag 1 Eetlepel (= 15ml) | |||
| Doseerinstructie | 3 maal per dag 15 ml | |||
| MBH identificatie | 92955660-5d8a-11e7-9598-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
1.6.2 Verstrekkingen Sluis
| Verstrekking | ||||
| Gegevenselement | Waarde | |||
| Identificatie | 84bd06a0-5d8a-11e7-9598-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Aanschrijfdatum | T- 43 dagen, om 12:45 | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Verstrekte hoeveelheid | 800 ml | |||
| Geneesmiddel - primaire code | NUTRIDRINK AARDBEI (code = '15132714' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '710695' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Verbruiksduur | 10 dagen | |||
| MBH identificatie | 84bd06a0-5d8a-11e7-9598-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Verstrekking | ||||
| Gegevenselement | Waarde | |||
| Identificatie | 92955660-5d8a-11e7-9598-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Aanschrijfdatum | T- 93 dagen, om 12:00 | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Verstrekte hoeveelheid | 1600 ml | |||
| Geneesmiddel - primaire code | NUTRIDRINK AARDBEI (code = '15132714' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '710695' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Verbruiksduur | 20 dagen | |||
| MBH identificatie | 92955660-5d8a-11e7-9598-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
1.7 Patiënt Aaltje A. Adelaar
| Patiënt | ||
| Gegevenselement | Waarde | |
| Naamgegevens | Aaltje A. Adelaar | |
| Identificatienummer | 999999011 [BSN] | |
| Geboortedatum | 1 jan 1950 | |
| Geslacht | Vrouw (code = 'F' in codeSystem 'AdministrativeGender') | |
1.7.1 Toedieningsafspraken Adelaar
| Toedieningsafspraak | ||||
| Gegevenselement | Waarde | |||
| Afspraakdatum | T | |||
| Gebruiksperiode | gedurende 60 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Geneesmiddel - primaire code | OXAZEPAM GF TABLET 10MG (code = '14243091' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '1148753' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Geneesmiddel - generiekere code | (code = '1023' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
| Gebruiksinstructie | ||||
| Omschrijving | gedurende 60 dagen, elke 4 dagen 2 stuks | |||
| Doseerinstructie | 1 maal per 4 dagen 2 stuks | |||
| MBH identificatie | 5ada2a80-100b-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
1.7.2 Verstrekkingen Adelaar
| Verstrekking | ||||
| Gegevenselement | Waarde | |||
| Identificatie | 5ada2a80-100b-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Aanschrijfdatum | T | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Verstrekte hoeveelheid | 35 stuks | |||
| Geneesmiddel - primaire code | OXAZEPAM GF TABLET 10MG (code = '14243091' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '1148753' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Geneesmiddel - generiekere code | (code = '1023' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
| MBH identificatie | 5ada2a80-100b-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
1.8 Patiënt Peter P. Veenoord
| Patiënt | ||
| Gegevenselement | Waarde | |
| Naamgegevens | Peter P. Veenoord | |
| Identificatienummer | 555555021 [BSN] | |
| Geboortedatum | 20 jan 1950 | |
| Geslacht | Man (code = 'M' in codeSystem 'AdministrativeGender') | |
1.8.1 Toedieningsafspraken Veenoord
| Toedieningsafspraak | ||||
| Gegevenselement | Waarde | |||
| Afspraakdatum | T- 20 dagen | |||
| Gebruiksperiode | Vanaf T- 20 dagen, gedurende 30 dagen tot en met T+ 9 dagen, om 00:00 | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Geneesmiddel - primaire code | Ibuprofen PCH tablet 600mg (code = '13550055' in codeSystem 'G-Standaard Artikel') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T- 20 dagen, gedurende 30 dagen tot en met T+ 9 dagen, om 00:00, 1 maal per dag 2 stuks | |||
| Doseerinstructie | 1 maal per dag 2 stuks | |||
| MBH identificatie | 9b084780-9401-11e9-b475-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Toedieningsafspraak | ||||
| Gegevenselement | Waarde | |||
| Afspraakdatum | T- 100 dagen | |||
| Gebruiksperiode | Vanaf T- 100 dagen, gedurende 29 dagen tot en met T- 72 dagen, om 00:00 | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Geneesmiddel - primaire code | XPRAEP SIROOP 2MG/ML (code = '12159220' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '101079' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Geneesmiddel - generiekere code | (code = '10960' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T- 100 dagen, gedurende 29 dagen tot en met T- 72 dagen, om 00:00, 1 maal per dag 10 ml | |||
| Doseerinstructie | 1 maal per dag 10 ml | |||
| MBH identificatie | f77406a0-ef17-11e4-b80c-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Toedieningsafspraak | ||||
| Gegevenselement | Waarde | |||
| Afspraakdatum | T- 50 dagen | |||
| Gebruiksperiode | Vanaf T- 50 dagen, gedurende 40 dagen tot en met T- 11 dagen, om 00:00 | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Geneesmiddel - primaire code | NUTRIDRINK AARDBEI NR16642 (code = '13659847' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '710695' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T- 50 dagen, gedurende 40 dagen tot en met T- 11 dagen, om 00:00, 2 maal per dag 50 ml | |||
| Doseerinstructie | 2 maal per dag 50 ml | |||
| MBH identificatie | fc93abe0-ef17-11e4-b80c-0800200ic9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Toedieningsafspraak | ||||
| Gegevenselement | Waarde | |||
| Afspraakdatum | T- 10 dagen | |||
| Gebruiksperiode | Vanaf T- 10 dagen, gedurende 30 dagen tot en met T+ 19 dagen, om 00:00 | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Geneesmiddel - primaire code | ASPIRINE TABLET 100MG (code = '13849247' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '202681' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Geneesmiddel - generiekere code | (code = '12548' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T- 10 dagen, gedurende 30 dagen tot en met T+ 19 dagen, om 00:00, 1 maal per 2 dagen 3 stuks zo nodig | |||
| Doseerinstructie | zo nodig 1 maal per 2 dagen 3 stuks | |||
| MBH identificatie | 0443e710-ef18-11e4-b80c-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Toedieningsafspraak | ||||
| Gegevenselement | Waarde | |||
| Afspraakdatum | T- 50 dagen | |||
| Gebruiksperiode | Vanaf T- 50 dagen, gedurende 7 dagen tot en met T- 44 dagen, om 00:00 | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Geneesmiddel - primaire code | ACENOCOUMAROL CF TABLET 1MG (code = '13918419' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '856126' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Geneesmiddel - generiekere code | (code = '20303' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T- 50 dagen, gedurende 7 dagen tot en met T- 44 dagen, om 00:00, Gebruik bekend | |||
| MBH identificatie | 08c37bc0-ef18-11e4-b80c-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Toedieningsafspraak | ||||
| Gegevenselement | Waarde | |||
| Afspraakdatum | T- 5 dagen | |||
| Gebruiksperiode | Vanaf T- 5 dagen, gedurende 7 dagen tot en met T+ 1 dag, om 00:00 | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Geneesmiddel - primaire code | OXAZEPAM GF TABLET 10MG (code = '14243091' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '1148753' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Geneesmiddel - generiekere code | (code = '1023' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T- 5 dagen, gedurende 7 dagen tot en met T+ 1 dag, om 00:00, 2 maal per dag 2 stuks | |||
| Doseerinstructie | 2 maal per dag 2 stuks | |||
| MBH identificatie | 0caac810-ef18-11e4-b80c-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
1.8.2 Verstrekkingen Veenoord
| Verstrekking | ||||
| Gegevenselement | Waarde | |||
| Identificatie | 9b084780-9401-11e9-b475-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Aanschrijfdatum | T- 20 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Verstrekte hoeveelheid | 60 stuks | |||
| Geneesmiddel - primaire code | Ibuprofen PCH tablet 600mg (code = '13550055' in codeSystem 'G-Standaard Artikel') | |||
| MBH identificatie | 9b084780-9401-11e9-b475-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Verstrekking | ||||
| Gegevenselement | Waarde | |||
| Identificatie | f77406a0-ef17-11e4-b80c-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Aanschrijfdatum | T- 100 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Verstrekte hoeveelheid | 290 ml | |||
| Geneesmiddel - primaire code | XPRAEP SIROOP 2MG/ML (code = '12159220' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '101079' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Geneesmiddel - generiekere code | (code = '10960' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
| MBH identificatie | f77406a0-ef17-11e4-b80c-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Verstrekking | ||||
| Gegevenselement | Waarde | |||
| Identificatie | fc93abe0-ef17-11e4-b80c-0800200ic9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Aanschrijfdatum | T- 50 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Verstrekte hoeveelheid | 4000 ml | |||
| Geneesmiddel - primaire code | NUTRIDRINK AARDBEI NR16642 (code = '13659847' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '710695' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| MBH identificatie | fc93abe0-ef17-11e4-b80c-0800200ic9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Verstrekking | ||||
| Gegevenselement | Waarde | |||
| Identificatie | 0443e710-ef18-11e4-b80c-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Aanschrijfdatum | T- 10 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Verstrekte hoeveelheid | 30 stuks | |||
| Geneesmiddel - primaire code | ASPIRINE TABLET 100MG (code = '13849247' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '202681' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Geneesmiddel - generiekere code | (code = '12548' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
| MBH identificatie | 0443e710-ef18-11e4-b80c-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Verstrekking | ||||
| Gegevenselement | Waarde | |||
| Identificatie | 08c37bc0-ef18-11e4-b80c-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Aanschrijfdatum | T- 50 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Verstrekte hoeveelheid | 14 stuks | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL CF TABLET 1MG (code = '13918419' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '856126' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Geneesmiddel - generiekere code | (code = '20303' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
| MBH identificatie | 08c37bc0-ef18-11e4-b80c-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Verstrekking | ||||
| Gegevenselement | Waarde | |||
| Identificatie | 0caac810-ef18-11e4-b80c-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Aanschrijfdatum | T- 5 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | ||||
| Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
| Organisatie naam | ||||
| Verstrekte hoeveelheid | 35 stuks | |||
| Geneesmiddel - primaire code | OXAZEPAM GF TABLET 10MG (code = '14243091' in codeSystem 'G-Standaard Artikel') | |||
| Geneesmiddel - generiekere code | (code = '1148753' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
| Geneesmiddel - generiekere code | (code = '1023' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
| MBH identificatie | 0caac810-ef18-11e4-b80c-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||